Measured by its ability to inhibit VEGF-dependent proliferation of human umbilical vein endothelial cells (HUVEC) in the presence of 10 ng/mL rhVEGF165. The ED50 for this effect is 40-120ng/mL.

Human KDR / VEGFR2 / FLK1 Protein (Recombinant Human IgG Fc, C-terminus)

ProteinLSBio Guarantee

Expression System	Human Embryonic Kidney 293
Format:	Lyophilized

$646.00each

Catalog Number: LS-G47205-200

Unit Size

Quantity

For bulk orders or custom formulations:

Overview

Description: KDR / VEGFR2 / FLK1 Protein LS-G47205 is a Recombinant Human KDR / VEGFR2 / FLK1 produced in HEK 293 Cells Met1-Lys327 with Human IgG Fc, C-terminus tag(s). It is biologically active and is low in endotoxin; Less than 1.0 EU/µg protein (determined by LAL method). For Research Use Only
Category: Proteins & Peptides > Proteins > Recombinant Proteins
Alternative Names: CD309 | Fetal liver kinase 1 | Fetal liver kinase-1 | KDR | FLK-1 | FLK1 | Kinase insert domain receptor | Quek1 | VEGFR | VEGFR2 | Soluble VEGFR2 | VEGF receptor 2 | VEGFR-2 | CD309 antigen | VEGF-R2
Origin Species: Human
NCBI GenBank: NM_002253
SwissProt: P35968

Protein

Expression System: Human Embryonic Kidney 293
Fusion Tag: Human IgG1 Fc Tag
Molecular Weight: The recombinant human KDR consists of 549 amino acids and predicts a molecular mass of 61.5 kDa.
Protein Type: Recombinant
Amino Acid Sequence

Format

Purity: >95%
Conjugate/Label: Unconjugated
Endotoxin Level: < 1.0 EU/µg
Format: Lyophilized
Formulation: Lyophilized from sterile PBS, pH 7.4, with 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Purity Measurement Method: SDS-PAGE (Coomassie Stain)